MK

Manju Kumari

Active Director Director DIN 09752858
DIN 09752858 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Manju Kumari

Data last updated:

Manju Kumari is a Director at Jivanex Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Jivanex Pharmaceutical Private Limited reported revenue of ₹3 Lakh (FY 2025).

DIN 09752858
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2022
Oldest Company Age 4 yrs
Largest company Jivanex Pharmaceutical Private Limited · ₹3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20222022₹3 Lakh (FY 2025)Active

Board colleagues of Manju Kumari

NameDINCompanyDesignation
Bebi Devi09752857Jivanex Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jivanex Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Manju Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manju Kumari

Manju Kumari currently holds 1 directorship: Jivanex Pharmaceutical Private Limited (Director, since 30 Sep 2022, revenue ₹3 Lakh (FY 2025)).

Manju Kumari was first appointed on 30 Sep 2022 as Director at Jivanex Pharmaceutical Private Limited.

The current boards of Manju Kumari's companies include Bebi Devi (Jivanex Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available